Trilynx: A Phase 3 Trial of Xevinapant and Concurrent Chemoradiotherapy (CRT) for Locally Advanced Head and Neck Cancer
Authors:
- J.D. SchoenfeldJSJ.D. Schoenfeld
- E. CohenECE. Cohen
- C.M. NuttingCNC.M. Nutting
- L. LicitraLLL. Licitra
- B. BurtnessBBB. Burtness
- M. OmarMOM. Omar
- F. BouissetFBF. Bouisset
- H. NauwelaertsHNH. Nauwelaerts
- Y. UrferYUY. Urfer
- C. ZannaCZC. Zanna
- J. Bourhis SrJSJ. Bourhis Sr
- 11 March 2022
- journal article
- abstracts
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 112 (5) , e20-e21